Clinical trial Recruiting at 9 sites Interventional Ages 18 and up

Comparing two methods of renal replacement therapy for patients on ECMO

Official title: Evaluation of Integrated Versus Parallel Continuous Renal Replacement Therapy Connection in ECMO Patients: a Randomized Controlled Trial

Run by Hospices Civils de Lyon · NCT06038162 · Data updated 2026-11-12

This study is testing two different ways to provide kidney treatment for patients on ECMO to see which method causes fewer complications like infections and bleeding.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment158 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations12 sites (Bordeaux and 11 other locations)
StatusRecruiting
StartedFebruary 7, 2024
Main results expectedFebruary 7, 2028
Study endsApril 7, 2028
Registry record updatedJanuary 20, 2026
Trial IDNCT06038162 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 75 who are on VA-ECMO and require continuous renal replacement therapy.

Probably not a fit

Patients who do not have suitable vascular access for RRT or those with high pressures on ECMO that prevent the use of a direct RRT catheter will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of two different methods for administering renal replacement therapy (RRT) in patients undergoing venoarterial extracorporeal membrane oxygenation (VA-ECMO). The two methods being compared are an integrated connection, where the RRT machine is directly incorporated into the ECMO circuit, and a parallel connection, which uses a separate vascular access. The goal is to determine which method may reduce complications such as infections and bleeding, which are critical concerns for patients on ECMO. The study aims to provide evidence-based recommendations for RRT in this high-risk population.

Why it matters

Potential benefit: If successful, this study could lead to improved outcomes and reduced complications for patients requiring renal replacement therapy while on ECMO.

How similar studies have gone: While there is limited research specifically comparing these two methods in ECMO patients, the evaluation of RRT in this context has been identified as a priority, indicating a need for further investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged above 18 years
* Patient on VA-ECMO who requires the initiation of continuous RRT during VA-ECMO treatment
* Patient with a foreseeable length of stay in intensive care greater than 24 hours

Exclusion Criteria:

* Patient who does not have a vascular capital allowing for the insertion of a new dialysis catheter to administer RRT and therefore cannot be randomized to the parallel connection group
* High pressures monitored on ECMO not allowing direct RRT catherter on ECMO
* Pregnant, parturient, or breastfeeding women
* Patient deprived of liberty by a judicial or administrative decision
* Patient under psychiatric care
* Patient subject to a legal protection measure (guardianship, curators)
* Patient not affiliated to a social security system
* Patient participating in another interventional research study in the field of extra purification renal

Where it's running

  • CHU de Bordeaux, GH Sud, Service d'anesthésie-réanimation cardiovasculaire, Hôpital cardiologique
    Bordeaux, France
    Recruiting
  • CHU de Clermont Ferrand, Pôle de médecine péri-opératoire/Chirurgie cardiaque, Hôpital Gabriel Montpied
    Clermont-Ferrand, France
    Recruiting
  • Centre Hospitalo Universitaire de Dijon, Unité Réanimation Cardio-Vasculaire,
    Dijon, France
    Recruiting
  • CHU de Grenoble, Service de réanimation cardiovasculaire et thoracique, Pôle anesthésie réanimation, Hôpital Nord
    Grenoble, France
    Recruiting
  • Hospices Civils de Lyon, Service d'Anesthésie-Réanimation cardiovasculaire, Hôpital Louis Pradel
    Lyon, France
    Recruiting
  • CHU de Montpellier, Département d'anesthésie-réanimation, Pôle Cœur-poumons, Hôpital Arnaud de Villeneuve
    Montpellier, France
    Recruiting
Show 6 more locations
  • APHP, Institut de Cardiologie, Service d'anesthésie-réanimation cardiovasculaire, Hôpital de la Pitié-Salpêtrière
    Paris, France
    Recruiting
  • APHP, Institut de cardiologie, Service de Médecine Intensive Réanimation, Hôpital Pitié-Salpêtrière
    Paris, France
    Recruiting
  • CHU de Saint Etienne, Hôpital Bellevue, Service de Réanimation polyvalente et soins intensifs post-opératoires
    Saint-Etienne, France
    Recruiting
  • Centre Hospitalo Universitaire de Lille, Institut Coeur Poumon
    Lille, France
    Not yet recruiting
  • Centre Hospitalo Universitaire de Toulouse, Hôpital Rangueil - Réanimation polyvalente
    Toulouse, France
    Not yet recruiting
  • Centre Hospitalo Universitaire de Toulouse, Unité de Chirurgie Cardiaque
    Toulouse, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.